SAFETY AND EFFICACY OF TOCILIZUMAB (ANTI-IL6R, TCZ) THERAPY IN THE TREATMENT OF CHRONIC ANTIBODY MEDIATED REJECTION (CABMR) IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS.

被引：0
|
作者：
Puliyanda, D. [1 ]
Kim, I. [2 ]
Choi, J. [2 ]
Haas, M. [2 ]
Zhang, X. [2 ]
Vo, A. [2 ]
Pizzo, H. [1 ]
Jordan, S. [2 ]
机构：
[1] Cedars Sinai Med Ctr, Pediat Nephrol, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA 90048 USA
来源：
PEDIATRIC TRANSPLANTATION | 2017年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
201.5
引用
收藏
页码：2 / 2
页数：1
相关论文
共 50 条
  • [41] Treatment of chronic active antibody-mediated rejection in renal transplant recipients - a single center retrospective study
    Chiu, Hsien-Fu
    Wen, Mei-Chin
    Wu, Ming-Ju
    Chen, Cheng-Hsu
    Yu, Tung-Min
    Chuang, Ya-Wen
    Huang, Shih-Ting
    Tsai, Shang-Feng
    Lo, Ying-Chih
    Ho, Hao-Chung
    Shu, Kuo-Hsiung
    BMC NEPHROLOGY, 2020, 21 (01)
  • [42] Treatment of chronic active antibody-mediated rejection in renal transplant recipients – a single center retrospective study
    Hsien-Fu Chiu
    Mei-Chin Wen
    Ming-Ju Wu
    Cheng-Hsu Chen
    Tung-Min Yu
    Ya-Wen Chuang
    Shih-Ting Huang
    Shang-Feng Tsai
    Ying-Chih Lo
    Hao-Chung Ho
    Kuo-Hsiung Shu
    BMC Nephrology, 21
  • [43] C1q-Fixing Human Leukocyte Antigen Assay for Chronic Antibody-Mediated Rejection in Renal Transplant Recipients.
    Kai, K.
    Tsutomu, I.
    Yashuo, M.
    Ogawa, Y.
    Koyama, I.
    Makajima, I.
    Fuchinoue, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 332 - 332
  • [44] Clazakizumab (CLZ, Anti-IL-6 Monoclonal Antibody) Treatment of Patients (Pts) with Chronic Antibody-Mediated Rejection (cABMR) Reduces Total Immunoglobulin (Ig) and Anti-HLA IgG Antibody Levels.
    Shin, B.
    Ammerman, N. F.
    Vo, A. A.
    Zhang, X.
    Jordan, S. C.
    Toyoda, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 667 - 667
  • [45] Clazakizumab (clz, Anti-il-6 Antibody) Treatment Affects Il-6/il-6r Signaling by Increasing Soluble Gp130 (sgp130) in Hla-sensitized Kidney Transplant Patients (hs Ktx Pts) Treated for Chronic Antibody-mediated Rejection (cabmr)
    Shin, B.
    Ge, S.
    Jimenez, A.
    Ammerman, N.
    Vo, A.
    Zhang, R.
    Jordan, S. C.
    Toyoda, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 737 - 738
  • [46] Retrospective Cohort Study Concerning Efficacy and Safety of Bortezomib in Combination With Or Without Rituximab in Antibody Mediated Rejection in Renal Transplant Recipients
    Duerr, M.
    Lachmann, N.
    Budde, K.
    Waiser, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [47] COMBINATION THERAPY OF RITUXIMAB AND INTRAVENOUS IMMUNOGLOBULIN AS AN EFFECTIVE TREATMENT FOR CHRONIC ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS
    Park, Woo Yeong
    Kang, Seong Sik
    Jin, Kyubok
    Park, Sung Bae
    Han, Seungyeup
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [48] COMBINATION THERAPY OF RITUXIMAB AND INTRAVENOUS IMMUNOGLOBULIN AS AN EFFECTIVE TREATMENT FOR CHRONIC ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS
    Park, Woo Yeong
    Yeo, Sang Mok
    Park, Hayeon
    Kang, Seong Sik
    Jin, Kyubok
    Park, Sung Bae
    Han, Seungyeup
    TRANSPLANT INTERNATIONAL, 2017, 30 : 527 - 527
  • [49] COMPARATIVE ANALYSIS OF THE EFFECT OF COMBINATION THERAPY WITH RITUXIMAB AND INTRAVENOUS IMMUNOGLOBULIN ON THE PROGRESSION OF CHRONIC ANTIBODY MEDIATED REJECTION IN RENAL TRANSPLANT RECIPIENTS
    Kim, Yaeni
    Kim, Hyun Seon
    Choi, Bum Soon
    Park, Cheol Whee
    Yang, Chul Woo
    Kim, Yong-Soo
    Chung, Byung Ha
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 324 - 324
  • [50] Tocilizumab (Anti-IL6-Receptor) Therapy For Donor-Specific Antibody (DSA plus ) Antibody Mediated Rejection (ABMR plus ) Resistant To IVIG plus Rituxan Treatment
    Choi, J.
    Kahwaji, J.
    Vo, A.
    Puliyanda, D.
    Peng, A.
    Villicana, R.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 128 - 129
12345